Cargando…
Melatonin Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib through the PERK-ATF4-Beclin1 Pathway
The mechanisms of resistance to the targeted drug sorafenib in the treatment of hepatocellular carcinoma (HCC) are poorly understood. The purpose of this study was to investigate the mechanism of sorafenib resistance and to elucidate the role of melatonin in overcoming sorafenib resistance. We first...
Autores principales: | Zhou, Bei, Lu, Qianqian, Liu, Jiatao, Fan, Lulu, Wang, Yu, Wei, Wei, Wang, Hua, Sun, Guoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743299/ https://www.ncbi.nlm.nih.gov/pubmed/31523192 http://dx.doi.org/10.7150/ijbs.32550 |
Ejemplares similares
-
PERK/ATF4-Dependent ZFAS1 Upregulation Is Associated with Sorafenib Resistance in Hepatocellular Carcinoma Cells
por: Lin, Jiunn-Chang, et al.
Publicado: (2021) -
Endoplasmic reticulum stress promotes sorafenib resistance via miR-188-5p/hnRNPA2B1-mediated upregulation of PKM2 in hepatocellular carcinoma
por: Zhou, Bei, et al.
Publicado: (2021) -
Melatonin relieves heat-induced spermatocyte apoptosis in mouse testes by inhibition of ATF6 and PERK signaling pathways
por: Qin, De-Zhe, et al.
Publicado: (2021) -
Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3
por: Hu, Zongqiang, et al.
Publicado: (2023) -
Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cells
por: Weng, Shunyan, et al.
Publicado: (2016)